Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lunsumio
Pharma
JPM24: Roche touts its rebound in hematology, led by Hemlibra
After a period of declining sales in hematology, Roche is rebounding quickly with blockbuster Hemlibra and new bispecifics Lunsumio and Columvi.
Kevin Dunleavy
Jan 9, 2024 4:26pm
ASH: Roche offers glimpse at Columvi-Polivy combo in DLBCL
Dec 11, 2023 7:00am
With Polivy beat, Roche fleshes out blood cancer ambitions
Oct 19, 2023 11:28am
AbbVie, Genmab's Epkinly shows promise in follicular lymphoma
Jun 28, 2023 3:08pm
'The Top Line': 2022's rotten tomatoes, plus this week's news
Jan 6, 2023 6:00am
FDA signs off on Roche's Lunsumio to treat follicular lymphoma
Dec 27, 2022 10:27am